Treatment Sequencing in Advanced RCC: From Evidence to Clinical Practice

home / insights / treatment-sequencing-in-advanced-rcc-from-evidence-to-clinical-practice

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, discuss the evolving treatment landscape for advanced renal cell carcinoma.

EP. 1: Overview of Renal Cell Carcinoma

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 17th 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, open the discussion with an overview of renal cell carcinoma.

EP. 2: Renal Cell Carcinoma Histology and Risk Stratification

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 17th 2023

Experts on renal cell carcinoma describe the RCC histologies and tools used for risk stratification.

EP. 3: Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 24th 2023

Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma.

EP. 4: Front Line Trials in Advanced RCC

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 24th 2023

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

EP. 5: Considerations in Advanced RCC Treatment Selection

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 31st 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, outline factors taken into consideration when selecting advanced RCC treatments.

EP. 6: Advanced RCC Treatment Options Post-Progression

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

March 31st 2023

Experts on renal cell carcinoma discuss post-progression treatment options for RCC.

EP. 7: TIVO-3 Trial: Tivozanib for Patients With Advanced RCC

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

April 7th 2023

A comprehensive overview of the TIVO-3 trial, which compared tivozanib with sorafenib in patients with advanced renal cell carcinoma.

EP. 8: Advanced RCC Treatments Following Prior Immune Checkpoint Inhibitors

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

April 7th 2023

Drs Barata and Garmezy give detailed thoughts on treating patients with advanced RCC who have received prior immune checkpoint inhibitors.

EP. 9: Clinical Pearls for Treating Advanced Renal Cell Carcinoma

Pedro Barata, MD, MSc;Benjamin Garmezy, MD

April 14th 2023

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, close their discussion with clinical pearls for community oncologists treating patients with advanced RCC.